A genome-wide association study and meta-analysis uncovered several possible ties to multiple keratinocyte cancer versus single keratinocyte cancer cases.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.
The study confirmed 17 previously identified loci, and uncovered 14 new ones that researchers hope can improve understanding of BCC pathogenesis and inform strategies for prevention.
An international team has uncovered roles for MYCN, PTPN14, and LATS1 mutations in the development and progression of skin basal cell carcinoma.
An analysis of angiosarcoma-derived cell lines identified a NUP160-SLC43A3 fusion that subsequently turned up in aggressive primary tumor samples.
The startup firm makes a device as an alternative to skin biopsy that can inform PCR- or NGS-based molecular profiling of the sampled region.
The report cited cost and a lack of awareness of such testing among doctors as the main obstacles to greater adoption of MDx testing for cancer patients.
Researchers from the Sanger Institute used genomic sequencing to study how somatic mutations build up prior to becoming cancerous.
A new genome-wide association study used imputation to test millions of variants in basal cell carcinoma cases and controls from Iceland.
NEW YORK (GenomeWeb News) – Verisante Technology said this week that it has begun submitting an application to the US Food and Drug Administration for 510(k) clearance of its Aura skin cancer detection device.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.